Northland Capmk Predicts Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Equities researchers at Northland Capmk issued their FY2026 earnings per share estimates for shares of Astera Labs in a research note issued on Thursday, January 2nd. Northland Capmk analyst G. Richard expects that the company will earn $0.71 per share for the year. Northland Capmk has a “Hold” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share.

Several other brokerages have also recently commented on ALAB. Morgan Stanley boosted their target price on shares of Astera Labs from $94.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, December 20th. Deutsche Bank Aktiengesellschaft upped their target price on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Stifel Nicolaus lifted their price target on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research note on Monday. JPMorgan Chase & Co. upped their price objective on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Finally, Citigroup assumed coverage on Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $105.75.

Astera Labs Stock Down 7.0 %

ALAB stock opened at $133.60 on Monday. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39. The business has a 50-day simple moving average of $112.23 and a 200 day simple moving average of $72.74.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The company’s revenue was up 47.1% on a year-over-year basis.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Hollencrest Capital Management bought a new position in Astera Labs during the third quarter worth $26,000. US Bancorp DE acquired a new stake in Astera Labs during the 3rd quarter worth about $46,000. First Horizon Advisors Inc. bought a new position in shares of Astera Labs in the 3rd quarter worth about $49,000. Allworth Financial LP lifted its stake in shares of Astera Labs by 445.5% in the 3rd quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock valued at $57,000 after purchasing an additional 891 shares during the period. Finally, GAMMA Investing LLC boosted its position in shares of Astera Labs by 78.3% during the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after purchasing an additional 224 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In related news, Director Jack R. Lazar sold 2,000 shares of Astera Labs stock in a transaction that occurred on Friday, October 11th. The stock was sold at an average price of $69.95, for a total value of $139,900.00. Following the transaction, the director now directly owns 135,000 shares of the company’s stock, valued at $9,443,250. The trade was a 1.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 47,667 shares of the stock in a transaction that occurred on Friday, October 11th. The shares were sold at an average price of $70.26, for a total transaction of $3,349,083.42. Following the sale, the chief executive officer now directly owns 728,420 shares of the company’s stock, valued at $51,178,789.20. This represents a 6.14 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,850,119 shares of company stock worth $178,711,939.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.